These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16460132)
1. Better analysis for better decisions: has pharmacoeconomics come of age? Drummond M; Sculpher M Pharmacoeconomics; 2006; 24(2):107-8. PubMed ID: 16460132 [No Abstract] [Full Text] [Related]
2. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective. Thwaites R; Townsend RJ Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomics and managed care: methodologic and policy issues. Luce BR Med Decis Making; 1998; 18(2 Suppl):S4-11. PubMed ID: 9566461 [No Abstract] [Full Text] [Related]
4. Pharmacoeconomics in South Africa. Jones JS S Afr Med J; 2006 Feb; 96(2):96. PubMed ID: 16541546 [No Abstract] [Full Text] [Related]
5. Pharmacoeconomics comes of age? Walley T; Breckenridge A Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057 [TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics and health policy. Current applications and prospects for the future. Greenberg PE; Arcelus A; Birnbaum HG; Cremieux PY; LeLorier J; Ouellette P; Slavin MB Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):425-32. PubMed ID: 10662390 [TBL] [Abstract][Full Text] [Related]
11. Economics, pharmaceuticals, and pharmacoeconomics. Johannesson M; O'Brien BJ Med Decis Making; 1998; 18(2 Suppl):S1-3. PubMed ID: 9566460 [No Abstract] [Full Text] [Related]
12. Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario? Preziosi P Nat Rev Drug Discov; 2004 Jun; 3(6):521-6. PubMed ID: 15173841 [No Abstract] [Full Text] [Related]
13. Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria. Postma MJ; Boersma C; Gansevoort RT Nephrol Dial Transplant; 2008 Apr; 23(4):1103-6. PubMed ID: 17210586 [No Abstract] [Full Text] [Related]
14. Applying patient outcomes and pharmacoeconomics in patient care. Proceedings of a conference. Boston, Massachusetts, September 1994. Am J Health Syst Pharm; 1995 Jul; 52(14 Suppl 3):S1-5. PubMed ID: 7552910 [No Abstract] [Full Text] [Related]
15. Pharmacoeconomics: state of the art in 1997. Schulman KA; Linas BP Annu Rev Public Health; 1997; 18():529-48. PubMed ID: 9143730 [TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomics and immunotherapy. Berto P Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():12-6. PubMed ID: 18924461 [TBL] [Abstract][Full Text] [Related]
17. Drug therapy: safety, effectiveness, and economics. Brandys J Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340 [TBL] [Abstract][Full Text] [Related]
18. Safe Therapeutic Economic Pharmaceutical Selection (STEPS): development, introduction and use in Northern Ireland. Scott M; Timoney M; Mairs J; Crealey G; Al Abaddi I; Brenninkmeijer R; Janknegt R; McElnay J Expert Opin Pharmacother; 2007 Oct; 8 Suppl 1():S57-63. PubMed ID: 17931080 [TBL] [Abstract][Full Text] [Related]
19. Is there a role for pharmacoeconomics in developing countries? Velasco RP; Teerawattananon Y Pharmacoeconomics; 2011 May; 29(5):433-5; author reply 436-7. PubMed ID: 21504242 [No Abstract] [Full Text] [Related]
20. Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapy. Hurley SF Pharmacoeconomics; 1992 Mar; 1(3):155-60. PubMed ID: 10147026 [No Abstract] [Full Text] [Related] [Next] [New Search]